Fibrinogen Human Terminated Phase 3 Trials for Blood Loss / Bone Tumour Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02153593Postoperative Bleeding Prevention in Massive Bone Tumour Resection